SUNRx 340B Webinar Series: A Post-Election Regulatory Update on 340B

Share on facebook
Share on twitter
Share on linkedin

SUNRx 340B Webinar Series: A Post-Election Regulatory Update on 340B

In case you missed the live session on January 26, SUNRx has posted an on-demand link exclusively for South Carolina Hospital Association members.

This webcast, hosted by Solvent Networks Endorsed Partner, SUNRx, featured special guest speaker, Jeff Davis of Baker Donelson, who covers the latest in 340B regulatory and legislative developments and shares insights on how you can best position your 340B program for success in 2021 and beyond.

Benefit from an overview of 340B including past, present, and future:

  • How we got here and what you need to know about the lawsuit over drug companies refusing 340B discounts
  • How the recent manufacturer actions may impact your 340B program
  • What you need to know about new guidance from HHS
  • Actions to consider now to position your program for the future

ACCESS ON-DEMAND WEBINAR HERE

 

Share this post with your friends

Share on facebook
Share on twitter
Share on linkedin
Share on email

Important information about COVID-19 from Solvent Networks